Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huron Capital is a leading middle-market private equity firm based in Detroit, Michigan, that was acquired by The Riverside Company in February 2024. The firm is well-regarded for its proprietary 'ExecFactor' investment model, which focuses on partnering with seasoned industry executives to build market-leading platforms through aggressive buy-and-build strategies. Huron Capital maintains a significant presence in the healthcare sector, primarily targeting healthcare services, medical products, and specialty distribution companies. While the firm does not engage in direct drug discovery or biotechnology research, its portfolio has included major players in laboratory testing, dental services, and behavioral health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huron Capital.